Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin twice-weekly versus daily prophylaxis pharmacokinetics study
2013-002848-93Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of micafungin in invasive mycoses (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Comparison of PK parameters. Started Nov 2013; status: completed.
02
Drugs
micafungin
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on 2013-002848-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002848-93.